+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 50Years
All Genders
ID07121894

Evaluating a Ketogenic Diet Intervention for Adults with Bipolar Depression An Open-Label Clinical Trial by Mayo Clinic

Led by Mayo Clinic · Updated on 2026-08-17

30

Participants Needed

1

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of a ketogenic diet on individuals with bipolar depression. This trial aims to understand how therapeutic precision ketosis relates to clinical symptoms and cardiometabolic health in people diagnosed with bipolar I or II disorder or bipolar schizoaffective disorder. The study focuses on treatment outcomes related to mood, metabolic measures, and inflammation. Participants will follow a modified ketogenic diet supported by structured, intensive guidance. They will also attend weekly behavioral support interviews with a psychiatrist to monitor mental health and mood stability. This open-label trial involves a single group of participants undergoing this dietary intervention over a six-month period. During the study, participants will undergo assessments of depressive symptoms, anxiety, psychosocial functioning, well-being, insulin resistance, mitochondrial function, inflammatory markers, and vascular health at the start and after six months. Researchers will track response and remission rates, clinically significant improvements, and the prevalence of disordered eating. Safety and health monitoring will continue throughout the study to evaluate the impact of the ketogenic diet on bipolar depression and associated cardiometabolic factors.

CONDITIONS

Brief Title

Ketogenic Intervention for Bipolar Depression

Research Team

K

Karin Lindstrom, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here